AU2006346318B2 - Injectable liquid paracetamol formulation - Google Patents

Injectable liquid paracetamol formulation Download PDF

Info

Publication number
AU2006346318B2
AU2006346318B2 AU2006346318A AU2006346318A AU2006346318B2 AU 2006346318 B2 AU2006346318 B2 AU 2006346318B2 AU 2006346318 A AU2006346318 A AU 2006346318A AU 2006346318 A AU2006346318 A AU 2006346318A AU 2006346318 B2 AU2006346318 B2 AU 2006346318B2
Authority
AU
Australia
Prior art keywords
paracetamol
solution
aqueous
solution according
color
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2006346318A
Other languages
English (en)
Other versions
AU2006346318A1 (en
Inventor
Raul Fernandez Plagaro
Faustino Huertas Munoz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfarma Laboratorio SL
Original Assignee
Genfarma Laboratorio SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38474429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2006346318(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genfarma Laboratorio SL filed Critical Genfarma Laboratorio SL
Publication of AU2006346318A1 publication Critical patent/AU2006346318A1/en
Application granted granted Critical
Publication of AU2006346318B2 publication Critical patent/AU2006346318B2/en
Priority to AU2011201253A priority Critical patent/AU2011201253B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2006346318A 2006-07-18 2006-07-18 Injectable liquid paracetamol formulation Active AU2006346318B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2011201253A AU2011201253B2 (en) 2006-07-18 2011-03-21 Injectable liquid paracetamol formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2006/070108 WO2008009756A1 (es) 2006-07-18 2006-07-18 Formulación líquida inyectable de paracetamol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2011201253A Division AU2011201253B2 (en) 2006-07-18 2011-03-21 Injectable liquid paracetamol formulation

Publications (2)

Publication Number Publication Date
AU2006346318A1 AU2006346318A1 (en) 2008-01-24
AU2006346318B2 true AU2006346318B2 (en) 2011-02-10

Family

ID=38474429

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2006346318A Active AU2006346318B2 (en) 2006-07-18 2006-07-18 Injectable liquid paracetamol formulation
AU2011201253A Active AU2011201253B2 (en) 2006-07-18 2011-03-21 Injectable liquid paracetamol formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2011201253A Active AU2011201253B2 (en) 2006-07-18 2011-03-21 Injectable liquid paracetamol formulation

Country Status (17)

Country Link
US (2) US9943479B2 (enExample)
EP (2) EP1889607B1 (enExample)
JP (1) JP4929352B2 (enExample)
AT (1) ATE432690T1 (enExample)
AU (2) AU2006346318B2 (enExample)
CA (1) CA2628806C (enExample)
CY (1) CY1110480T1 (enExample)
DE (1) DE602007001215D1 (enExample)
DK (1) DK1889607T3 (enExample)
ES (1) ES2327286T3 (enExample)
HR (1) HRP20090350T1 (enExample)
MA (1) MA31346B1 (enExample)
PL (1) PL1889607T3 (enExample)
PT (1) PT1889607E (enExample)
RU (1) RU2419421C2 (enExample)
SI (1) SI1889607T1 (enExample)
WO (1) WO2008009756A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
DK2525796T3 (en) * 2010-01-21 2016-07-04 Aprea Ab An aqueous solution comprising 3-quinuclidinoner for the treatment of hyperproliferative disease, autoimmune disease and heart disease
EP2377516B1 (en) 2010-04-14 2012-06-20 B. Braun Melsungen AG Acetaminophen composition
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) * 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
WO2016013049A1 (en) * 2014-07-25 2016-01-28 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
PL3411004T3 (pl) * 2016-02-05 2021-10-18 Innopharma, Inc. Sposób wytwarzania trwałego gotowego do użycia worka infuzyjnego z preparatem wrażliwym na utlenianie

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751875A1 (fr) * 1996-08-05 1998-02-06 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619A1 (fr) * 2000-06-06 2001-12-07 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
EP0916347B1 (en) * 1997-11-18 2003-02-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440815A (en) 1981-06-29 1984-04-03 Abbott Laboratories Clear, autoclavable plastic formulation for medical liquid containers
KR100226191B1 (ko) 1997-04-03 1999-10-15 구광시 음료용 플라스틱 병
JP3674685B2 (ja) * 1997-10-23 2005-07-20 森永乳業株式会社 液体の連続式加熱殺菌方法及び装置
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
HUP0402549A3 (en) 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
EP1508566B1 (en) 2002-05-27 2007-07-18 Kyorin Pharmaceutical Co., Ltd. (2s)-2-ethylphenylpropionic acid derivative
WO2004004705A2 (en) * 2002-07-03 2004-01-15 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751875A1 (fr) * 1996-08-05 1998-02-06 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP0916347B1 (en) * 1997-11-18 2003-02-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
FR2809619A1 (fr) * 2000-06-06 2001-12-07 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Also Published As

Publication number Publication date
RU2009105480A (ru) 2010-08-27
CA2628806A1 (en) 2008-01-24
RU2419421C2 (ru) 2011-05-27
ATE432690T1 (de) 2009-06-15
US9943492B2 (en) 2018-04-17
SI1889607T1 (sl) 2009-10-31
AU2006346318A1 (en) 2008-01-24
CA2628806C (en) 2012-08-21
US20090215903A1 (en) 2009-08-27
PL1889607T3 (pl) 2009-10-30
PT1889607E (pt) 2009-07-20
EP2100596A3 (en) 2010-04-28
CY1110480T1 (el) 2015-04-29
JP4929352B2 (ja) 2012-05-09
WO2008009756A1 (es) 2008-01-24
EP2100596A2 (en) 2009-09-16
DK1889607T3 (da) 2009-07-27
JP2009543851A (ja) 2009-12-10
US20160199325A1 (en) 2016-07-14
MA31346B1 (fr) 2010-05-03
AU2011201253B2 (en) 2012-03-29
US9943479B2 (en) 2018-04-17
DE602007001215D1 (de) 2009-07-16
ES2327286T3 (es) 2009-10-27
EP1889607B1 (en) 2009-06-03
HRP20090350T1 (en) 2009-08-31
AU2011201253A1 (en) 2011-04-07
EP1889607A1 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
AU2011201253B2 (en) Injectable liquid paracetamol formulation
US2980584A (en) Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
AU2017310916B2 (en) PD-1 antibody formulation
US20080187604A1 (en) Liquid chalcogenide compositions and methods of manufacturing and using the same
US8226986B2 (en) Liquid chalcogenide compositions and methods of manufacturing and using the same
US20250302779A1 (en) Stable aqueous hydroxycarbamide solution
JPH03173822A (ja) セファロスポリン系薬物を含有する注射用組成物
JPS5914447B2 (ja) ｐＨおよび色安定化非経口投与用水性抗性物質組成物
CZ20023849A3 (cs) Nové farmaceutické prostředky na bázi alfa-(2,4-disulfofenyl)-N-terc. butylnitronu
DE19818802A1 (de) Stabile Mitoxantron-Lösungen
US4582845A (en) Pharmaceutical composition for injection
US2720482A (en) Stabilized streptomycin solutions
BG60609B1 (bg) Инжекционен разтвор и метод за получаването му
RS51179B (sr) Tečne injektabilne formulacije paracetamola
KR100473963B1 (ko) 퀴놀론계항균화합물의주사또는주입용수용액제제
WO2011063605A1 (zh) 一种化合物/葡萄糖制剂
DE3839839C2 (enExample)
BR102014005885B1 (pt) Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
CN119385939A (zh) 一种左卡尼汀口服溶液及其制备方法
JP2004000364A (ja) 消毒剤
HU204436B (en) Process for producing parenteral aqouos pharmaceutical composition containing tobramycin, apramycin or gentamycin

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)